isradipine has been researched along with Chronic Kidney Failure in 7 studies
Isradipine: A potent antagonist of CALCIUM CHANNELS that is highly selective for VASCULAR SMOOTH MUSCLE. It is effective in the treatment of chronic stable angina pectoris, hypertension, and congestive cardiac failure.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Similar results were obtained when spirapril was combined with 5 mg isradipine in the initial and final single dose, or in the 3 months' treatment (5 mg o." | 6.69 | Acute and chronic effects of spirapril, alone or in combination with isradipine on kidney function and blood pressure in patients with reduced kidney function and hypertension. ( Boner, G; Erman, A; Rosenfeld, J; Shohat, J; Wittenberg, C, 1999) |
| "In a double-blind, randomized trial with 26 male white patients with essential hypertension in World Health Organization Stages I and II, we examined the impact of calcium entry blockade (5 to 10 mg/day isradipine, N = 14) and beta-blockade (100 to 200 mg/day metoprolol, N = 12) on early markers of hypertensive nephropathy before and after 7 weeks' treatment." | 5.07 | Impact of antihypertensive therapy with isradipine and metoprolol on early markers of hypertensive nephropathy. ( Rockstroh, J; Rüddel, H; Schächinger, H; Schlebusch, H; Schmieder, RE; Schulte, W, 1992) |
| "Sixty patients with chronic renal failure and hypertension were enrolled in the study." | 2.70 | A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension. ( Jensen, HA; Ladefoged, SD; Mehlsen, J; Møller, ML; Petersen, JR; Petersen, LJ; Talleruphuus, U, 2001) |
| " Similar results were obtained when spirapril was combined with 5 mg isradipine in the initial and final single dose, or in the 3 months' treatment (5 mg o." | 2.69 | Acute and chronic effects of spirapril, alone or in combination with isradipine on kidney function and blood pressure in patients with reduced kidney function and hypertension. ( Boner, G; Erman, A; Rosenfeld, J; Shohat, J; Wittenberg, C, 1999) |
| "Both isradipine treatments were equally effective in reducing the mean 24-h BP levels." | 2.68 | Time-dependent effect of isradipine on the nocturnal hypertension in chronic renal failure. ( degli Uberti, EC; Fersini, C; Manfredini, R; Portaluppi, F; Vergnani, L, 1995) |
| " Considering the interpatient variability in isradipine disposition and the lack of significant differences in CLo between groups, no clear-cut dosing regimen alterations, based on single-dose data, are warranted in renal impairment." | 1.27 | The effects of renal function on the disposition of isradipine. ( Blouin, RA; Chandler, MH; Cutler, RE; Gonasun, LM; Schran, HF; Smith, AJ, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Portaluppi, F | 1 |
| Vergnani, L | 1 |
| Manfredini, R | 1 |
| degli Uberti, EC | 1 |
| Fersini, C | 1 |
| Wittenberg, C | 2 |
| Erman, A | 2 |
| Shohat, J | 2 |
| Boner, G | 2 |
| Rosenfeld, J | 1 |
| Petersen, LJ | 1 |
| Petersen, JR | 1 |
| Talleruphuus, U | 1 |
| Møller, ML | 1 |
| Ladefoged, SD | 1 |
| Mehlsen, J | 1 |
| Jensen, HA | 1 |
| Francischetti, EA | 1 |
| Schmieder, RE | 1 |
| Rüddel, H | 1 |
| Schlebusch, H | 1 |
| Rockstroh, J | 1 |
| Schächinger, H | 1 |
| Schulte, W | 1 |
| Chandler, MH | 1 |
| Schran, HF | 1 |
| Cutler, RE | 1 |
| Smith, AJ | 1 |
| Gonasun, LM | 1 |
| Blouin, RA | 1 |
1 review available for isradipine and Chronic Kidney Failure
| Article | Year |
|---|---|
[Prevention of hypertensive nephropathy: what more besides arterial blood pressure control?].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Humans; Hypertens | 1992 |
5 trials available for isradipine and Chronic Kidney Failure
| Article | Year |
|---|---|
Time-dependent effect of isradipine on the nocturnal hypertension in chronic renal failure.
Topics: Antihypertensive Agents; Blood Pressure; Circadian Rhythm; Cross-Over Studies; Delayed-Action Prepar | 1995 |
Concomitant administration of isradipine and spirapril prevents reduction of renal function induced by acute administration of spirapril in patients with reduced renal function.
Topics: Angiotensin-Converting Enzyme Inhibitors; Drug Combinations; Enalapril; Humans; Isradipine; Kidney; | 1994 |
Acute and chronic effects of spirapril, alone or in combination with isradipine on kidney function and blood pressure in patients with reduced kidney function and hypertension.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Drug | 1999 |
A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
Topics: Adolescent; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel B | 2001 |
Impact of antihypertensive therapy with isradipine and metoprolol on early markers of hypertensive nephropathy.
Topics: Antihypertensive Agents; Dihydropyridines; Double-Blind Method; Humans; Hypertension; Isradipine; Ki | 1992 |
1 other study available for isradipine and Chronic Kidney Failure
| Article | Year |
|---|---|
The effects of renal function on the disposition of isradipine.
Topics: Adult; Aged; Calcium Channel Blockers; Female; Humans; Isradipine; Kidney Failure, Chronic; Male; Mi | 1988 |